Previous studies have demonstrated that FX significantly reduces mortality in a CLP-induced sepsis mouse model via interferon regulatory factor 3 (IRF3), effectively suppresses pro-inflammatory cytokines and ROS, improves pathological damage, and activates autoimmune cells [15,16,17,18]. The gene discussed is IRF3; the disease is Sepsis.